Federal Register / Vol. 79, No. 211 / Friday, October 31, 2014 / Notices 64799 

Docket # 

(FHFAID) Member City State 

13260 ............ Bank of Eastern Oregon ...................................................................................... Heppner ................................................ OR 

55342 ............ Great Western Insurance Company .................................................................... Ogden ................................................... UT 

55117 ............ Transportation Alliance Bank, Inc. ....................................................................... Ogden ................................................... UT 

55245 ............ Granite Federal Credit Union ............................................................................... Salt Lake City ....................................... UT 

55213 ............ Cyprus Credit Union ............................................................................................. West Jordan .......................................... UT 

55118 ............ Great Northwest Credit Union .............................................................................. Aberdeen .............................................. WA 

4347 .............. Riverview Community Bank ................................................................................. Camas ................................................... WA 

14623 ............ The Bank of Washington ..................................................................................... Edmonds ............................................... WA 

16274 ............ Fife Commercial Bank .......................................................................................... Fife ........................................................ WA 

1925 .............. Olympia FS & LA ................................................................................................. Olympia ................................................. WA 

16193 ............ TwinStar Credit Union .......................................................................................... Olympia ................................................. WA 

1528 .............. First FS & LA of Port Angeles ............................................................................. Port Angeles ......................................... WA 

16484 ............ Seattle Savings Bank ........................................................................................... Seattle ................................................... WA 

16506 ............ Our Community Federal Credit Union ................................................................. Shelton .................................................. WA 

921 ................ Yakima FS & LA .................................................................................................. Yakima .................................................. WA 

55069 ............ Solarity Credit Union ............................................................................................ Yakima .................................................. WA 

3903 .............. Buffalo Federal Bank ........................................................................................... Buffalo ................................................... WY 

10647 ............ Hilltop National Bank ............................................................................................ Casper .................................................. WY 

55077 ............ Wyhy Credit Union ............................................................................................... Cheyenne .............................................. WY 

3790 .............. Big Horn Federal Savings Bank .......................................................................... Greybull ................................................. WY 

15949 ............ Oregon Trail Bank ................................................................................................ Guernsey .............................................. WY 

9491 .............. Rocky Mountain Bank .......................................................................................... Rock Springs ........................................ WY 

13484 ............ RSNB Bank .......................................................................................................... Rock Springs ........................................ WY 

15713 ............ Pinnacle Bank—Wyoming .................................................................................... Torrington .............................................. WY 

II. Public Comments 

To encourage the submission of 

public comments on the community 

support performance of Bank members, 

on or before November 17, 2014, each 

Bank will notify its Advisory Council, 

nonprofit housing developers, 

community groups and other interested 

parties in its district of the members of 

the Bank selected for this review cycle. 

12 CFR 1290.2(b)(2)(ii). In reviewing a 

member for community support 

compliance, FHFA will consider any 

public comments it has received 

concerning the member. 12 CFR 

1290.2(d). To ensure consideration by 

FHFA, comments concerning the 

community support performance of 

members selected for this review cycle 

must be submitted to FHFA, either by 

electronic mail to 

hmgcommunitysupportprogram@

fhfa.gov, or by fax to 202–649–4130, on 

or before December 15, 2014. 

Dated: October 27, 2014. 

Melvin L. Watt, 

Director, Federal Housing Finance Agency. 

[FR Doc. 2014–25970 Filed 10–30–14; 8:45 am] 

BILLING CODE 8070–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Findings of Research Misconduct 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the Office of Research Integrity (ORI) 

has taken final action in the following 

case: 

Bijan Ahvazi, Ph.D., National 

Institutes of Health: Based on the report 

of an investigation conducted by the 

National Institutes of Health (NIH) and 

additional analysis by ORI in its 

oversight review, ORI found that Dr. 

Bijan Ahvazi, former Director of the 

Laboratory of X-ray Crystallography, 

National Institute of Arthritis and 

Musculoskeletal and Skin Diseases 

(NIAMS), NIH, engaged in research 

misconduct in research supported by 

the Intramural Program at NIAMS, NIH. 

ORI found that Respondent engaged 

in research misconduct by falsifying 

data related to or in the following 

published papers: 

1. Ahvazi, B., Boeshans, K.M., Idler, 

W., Baxa, U., & Steinert, P.M. 

‘‘Structural basis for the coordinated 

regulation of transglutaminase 3 by 

guanine nucleotides and calcium/

magnesium.’’ J. Biol. Chem. 

279(8):7180–92, 2004 Feb 20 

(withdrawn) (hereinafter ‘‘JBC 2004a’’) 

2. Ahvazi, B., Boeshans, K.M., & 

Steinert, P.M. ‘‘Crystal structure of 

transglutaminase 3 in complex with 

BMP: Structural basis for nucleotide 

specificity.’’ J. Biol. Chem. 279:26716– 

25, 2004 (withdrawn) (hereinafter ‘‘JBC 

2004b’’) 

3. Ahvazi, B., Boeshans, K.M., Idler, 

W.,& Cooper, A.J.L. ‘‘Crystal structure of 

transglutaminase 3-cystamine complex: 

Binding of two cystamines to the 

nucleotide-binding pocket. M6:06060, 

Submitted to J. Biol. Chem., 2006 

(rejected) (hereinafter ‘‘JBC 2006’’). 

Specifically, ORI finds that 

Respondent: 

1. Falsely labeled Figure 3A in JBC 

2004b representing an isothermal 

calorimetric titration (ITC) experiment 

using guanine monophosphate (GMP) 

and transglutaminase 3 (TGase 3) when 

the figure was actually a relabeled 

version of an unrelated experiment that 

Respondent previously published as 

Figure 1A in JBC 2004a. 

2. falsified Figure 4B, Figure 4C, and 

Figure 6D in JBC 2004b and Figure 5E 

in JBC 2006, by altering the original data 

in the following ways to represent the 

desired experiment: 

a. Falsified Figure 4B in JBC 2004b, by 

adding multiple data points to 

titration curves for four different 

concentrations of TGase 3 bound by 

different concentrations of tagged 

GTPgS and deleting two (2) outlying 

data points from one of the curves 

b. falsified Figure 4C in JBC 2004 b, 

representing a competition assay for 

the release of tagged GTPgS bound 

to TGase 3, by (1) falsely claiming 

that the release of the tagged 

nucleotide occurred with the 

addition of untagged GMP, when 

the result was from an assay using 

untagged GDP, (2) adding 

additional data points onto the 

titration curves, and (3) altering the 

scale of the abscissa 

c. falsified Figure 6D in JBC 2004b, by 

using the false Figure 4B to also 

represent an additional competition 

experiment using unmodified 

nucleotide analog compounds and 


asabaliauskas on DSK5VPTVN1PROD with NOTICES
64800 Federal Register / Vol. 79, No. 211 / Friday, October 31, 2014 / Notices 

ATP; specifically, Respondent (1) 

falsified the units and labels of the 

axes, (2) falsified the labels of the 

curves, and (3) vertically inverted 

the curves 

d. falsified Figure 5E in the JBC 2006 

manuscript, representing a 

competition experiment for the 

release of tagged GTPgS bound to 

TGase 3 with the addition of 

cystamine, when the actual 

experiment was a competition 

experiment with the addition of 

untagged nucleotides. 

Dr. Ahvazi has entered into a 

Voluntary Settlement Agreement 

(Agreement) and has voluntarily agreed 

for a period of two (2) years, beginning 

on October 7, 2014: 

(1) To have his U.S. Public Health 

Service (PHS) research supervised and 

to notify any employer(s)/institution(s) 

at which he may participate in PHS 

funded projects of the terms of his 

supervision; Respondent agrees that 

prior to the submission of an 

application for PHS support for a 

research project on which the 

Respondent’s participation is proposed 

and prior to Respondent’s participation 

in any capacity on PHS-supported 

research, Respondent shall ensure that a 

plan for supervision of Respondent’s 

duties is submitted to ORI for approval; 

the supervision plan must be designed 

to ensure the scientific integrity of 

Respondent’s research; Respondent 

agrees that he shall not participate in 

any PHS-supported research until such 

a supervision plan is submitted to and 

approved by ORI; Respondent agrees to 

maintain responsibility for compliance 

with the agreed upon supervision plan; 

(2) that any institution employing him 

to work on PHS-supported projects shall 

submit, in conjunction with each 

application for PHS funds, or report, 

manuscript, or abstract involving PHSsupported research in which 

Respondent is involved, a certification 

to ORI that the data provided by 

Respondent are based on actual 

experiments or are otherwise 

legitimately derived and that the data, 

procedures, and methodology are 

accurately reported in the application, 

report, manuscript, or abstract; and 

(3) to exclude himself voluntarily 

from serving in any advisory capacity to 

PHS including, but not limited to, 

service on any PHS advisory committee, 

board, and/or peer review committee, or 

as a consultant. 

FOR FURTHER INFORMATION CONTACT: 

Acting Director, Office of Research 

Integrity, 1101 Wootton Parkway, Suite 

750, Rockville, MD 20852, (240) 453– 

8200. 

Donald Wright, 

Acting Director, Office of Research Integrity. 

[FR Doc. 2014–25887 Filed 10–30–14; 8:45 am] 

BILLING CODE 4150–31–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Intent To Award Ebola 

Response Outbreak Funding to 

Eligible Ministries of Health and Their 

Bona Fide Agents 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: This notice provides public 

announcement of CDC’s intent to award 

Ebola appropriations to select Ministries 

of Health and their bona fide agents for 

response to the Ebola outbreak funding. 

This award was proposed in Fiscal Year 

(FY) 2015 under funding opportunity 

announcement GH14–1418, ‘‘Protecting 

and Strengthening Public Health 

Impact, Systems, Capacity, and 

Security.’’ 

This notice replaces the Notice of 

Intent to award Ebola Response 

outbreak funding to eligible Ministries 

of Health and their bona fide agents 

which was published on October 22, 

2014 (79 FR 63126, October 22, 2014). 

CDC is correcting the application date, 

award dates, amount of funding 

available, and one of the points of 

contact. 

Catalogue of Federal Domestic Assistance 

Number (CFDA): 93.318. 

Authority: Public Health Service 301(a) 

and 307 as amended [42 U.S.C 241 and 242l]. 

Multiple awards may be awarded to 

grantees totaling $300,000 to $1,500,000 

per award for the Ebola response 

outbreak. 

Funding is appropriated under the 

Continuing Appropriations Resolution, 

2015, Public Law 113–164, 128 Stat. 

1867 (2014). 

DATES: Anticipated award date is 12/11/ 

2014. 

Application Due Date: 12/1/2014. 

Project Number is CDC–RFA–GH14– 

1418. 

ADDRESSES: CDC has waived the 

Grants.gov electronic submission 

process for this requirement. Recipients 

are hereby authorized to submit a paper 

copy application for (CDC–RFA–GH14– 

1418) via Express Mail (i.e. FedEx, UPS, 

or DHL) and send the application via 

email. Mailed applications must be 

address to Dionne Bounds, Centers for 

Disease Control and Prevention, 2920 

Brandywine Road, Atlanta, GA 30341, 

telephone (770) 488–2082, or email at 

DBounds@cdc.gov. The application 

must include a detailed line-item budget 

and justification to support the Ebola 

activities from December 11, 2014 to 

September 29, 2015. Please download 

the following to complete the 

application package: http://

apply07.grants.gov/apply/forms/

sample/SF424_2_1-V2.1.pdf— 

Application Package; http://

www.cdc.gov/od/pgo/funding/docs/

CertificationsForm.pdf—Certifications; 

http://www.cdc.gov/od/pgo/funding/

grants/Budget_Preparation_Guidelines_

8-2-12.docx—CDC–PGO Budget 

Guidelines; http://apply07.grants.gov/

apply/forms/sample/SF424A-V1.0.pdf— 

SF–424A Budget Information. 

All applications must be submitted to 

and received by the Grants Management 

Officer (GMO) no later than 11:59 p.m. 

EST on December 1, 2014 and please 

provide the GMO a PDF version of the 

application by email to the following 

email address: ogsghebolaresponse@

cdc.gov subject line: CDC–RFA–GH14– 

1418. 

Applicants will be provided with the 

Funding Opportunity Announcement 

(FOA) and additional application 

submission guidance via email 

notification. Applicants may contact the 

POCs listed with questions regarding 

the application process. 

FOR FURTHER INFORMATION CONTACT: 

For programmatic or technical 

assistance: Kawi Mailutha, Project 

Officer, Department of Health and 

Human Services, Centers for Disease 

Control and Prevention, 1600 Clifton 

Rd. MS E–29, Atlanta, GA 30333, 

Telephone: 404–639–8093, E-Mail: 

KMailutha@cdc.gov. 

For financial, awards management, or 

budget assistance: Dionne Bounds, 

Grants Management Officer, Centers for 

Disease Control and Prevention, 2920 

Brandywine Road, Atlanta, GA 30341, 

Telephone (770) 488–2082, Email: 

DBounds@cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

purpose of this notice is to solicit 

applications from eligible Ministries of 

Health and their bona fide agents to 

quickly arrest the spread of the Ebola 

virus in West Africa and contain the 

disease as quickly as possible. The 

funding will support the impacted 

countries and the surrounding countries 

to combat this health crisis. This 

funding will target the following 

countries: Liberia, Sierra Leone, Guinea, 


asabaliauskas on DSK5VPTVN1PROD with NOTICES